ArticleTrials2022

Repair of acute respiratory distress syndrome by stromal cell administration (REALIST): a structured study protocol for an open-label dose-escalation phase 1 trial followed by a randomised, triple-blind, allocation concealed, placebo-controlled phase 2 trial.

Ellen Gorman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.